NMBA Reversal and Postoperative Urinary Retention

Clinical trial NCT06948409 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06948409
Sponsor: Beth Israel Deaconess Medical Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Neuromuscular Blocking Agents Urinary Retention After Procedure Urinary Retention Postoperative Neuromuscular Blockade Reversal Agent Neuromuscular Blockade Costs Atropine Sugammadex Glycopyrrolate Neostigmine Anesthesia

Start date: 2025-06-08
Primary completion: 2025-08-31
Enrollment: 70000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.